Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review.

ABSTRACT:

Background

A Task Force from the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) provides recommendations on how to systematically identify and appraise health state utility (HSU) weights for cost-effectiveness analyses. We applied these recommendations to conduct a systematic review (SR) to identify HSU weights for different stages of chronic kidney disease (CKD), renal replacement therapy (RRT) and complications.

Methods

MEDLINE® and Embase were searched for interventional and non-interventional studies reporting HSU weights for patients with CKD stages 1-5 or RRT. As per ISPOR Task Force Guidance, study quality criteria, applicability for Health Technology Assessment (HTA) and generalisability to a broad CKD population were used to grade studies a

SUBMITTER: Cooper JT 

PROVIDER: S-EPMC7507735 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature